|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 33002 |
FusionGeneSummary for SEC13_GOLPH3L |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: SEC13_GOLPH3L | Fusion gene ID: 33002 | Hgene | Tgene | Gene symbol | SEC13 | GOLPH3L | Gene ID | 6396 | 55204 |
| Gene name | SEC13 homolog, nuclear pore and COPII coat complex component | golgi phosphoprotein 3 like | |
| Synonyms | D3S1231E|SEC13L1|SEC13R|npp-20 | GPP34R | |
| Cytomap | 3p25.3 | 1q21.3 | |
| Type of gene | protein-coding | protein-coding | |
| Description | protein SEC13 homologGATOR complex protein SEC13SEC13 homolog, nuclear pore and COPII coating complex componentSEC13-like 1 isoformSEC13-like protein 1SEC13-related protein | Golgi phosphoprotein 3-likeGPP34-related protein | |
| Modification date | 20180523 | 20180523 | |
| UniProtAcc | P55735 | Q9H4A5 | |
| Ensembl transtripts involved in fusion gene | ENST00000397109, ENST00000337354, ENST00000350697, ENST00000397117, ENST00000383801, ENST00000492602, | ENST00000271732, ENST00000540514, ENST00000479757, | |
| Fusion gene scores | * DoF score | 1 X 1 X 1=1 | 8 X 4 X 7=224 |
| # samples | 1 | 8 | |
| ** MAII score | log2(1/1*10)=3.32192809488736 | log2(8/224*10)=-1.48542682717024 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: SEC13 [Title/Abstract] AND GOLPH3L [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | SEC13 | GO:0090110 | cargo loading into COPII-coated vesicle | 17499046|18843296 |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| TCGA | LD | BLCA | TCGA-ZF-AA4T-01A | SEC13 | chr3 | 10362734 | - | GOLPH3L | chr1 | 150634404 | - |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| intron-3CDS | ENST00000397109 | ENST00000271732 | SEC13 | chr3 | 10362734 | - | GOLPH3L | chr1 | 150634404 | - |
| intron-3CDS | ENST00000397109 | ENST00000540514 | SEC13 | chr3 | 10362734 | - | GOLPH3L | chr1 | 150634404 | - |
| intron-intron | ENST00000397109 | ENST00000479757 | SEC13 | chr3 | 10362734 | - | GOLPH3L | chr1 | 150634404 | - |
| 5UTR-3CDS | ENST00000337354 | ENST00000271732 | SEC13 | chr3 | 10362734 | - | GOLPH3L | chr1 | 150634404 | - |
| 5UTR-3CDS | ENST00000337354 | ENST00000540514 | SEC13 | chr3 | 10362734 | - | GOLPH3L | chr1 | 150634404 | - |
| 5UTR-intron | ENST00000337354 | ENST00000479757 | SEC13 | chr3 | 10362734 | - | GOLPH3L | chr1 | 150634404 | - |
| In-frame | ENST00000350697 | ENST00000271732 | SEC13 | chr3 | 10362734 | - | GOLPH3L | chr1 | 150634404 | - |
| In-frame | ENST00000350697 | ENST00000540514 | SEC13 | chr3 | 10362734 | - | GOLPH3L | chr1 | 150634404 | - |
| 5CDS-intron | ENST00000350697 | ENST00000479757 | SEC13 | chr3 | 10362734 | - | GOLPH3L | chr1 | 150634404 | - |
| intron-3CDS | ENST00000397117 | ENST00000271732 | SEC13 | chr3 | 10362734 | - | GOLPH3L | chr1 | 150634404 | - |
| intron-3CDS | ENST00000397117 | ENST00000540514 | SEC13 | chr3 | 10362734 | - | GOLPH3L | chr1 | 150634404 | - |
| intron-intron | ENST00000397117 | ENST00000479757 | SEC13 | chr3 | 10362734 | - | GOLPH3L | chr1 | 150634404 | - |
| 5UTR-3CDS | ENST00000383801 | ENST00000271732 | SEC13 | chr3 | 10362734 | - | GOLPH3L | chr1 | 150634404 | - |
| 5UTR-3CDS | ENST00000383801 | ENST00000540514 | SEC13 | chr3 | 10362734 | - | GOLPH3L | chr1 | 150634404 | - |
| 5UTR-intron | ENST00000383801 | ENST00000479757 | SEC13 | chr3 | 10362734 | - | GOLPH3L | chr1 | 150634404 | - |
| intron-3CDS | ENST00000492602 | ENST00000271732 | SEC13 | chr3 | 10362734 | - | GOLPH3L | chr1 | 150634404 | - |
| intron-3CDS | ENST00000492602 | ENST00000540514 | SEC13 | chr3 | 10362734 | - | GOLPH3L | chr1 | 150634404 | - |
| intron-intron | ENST00000492602 | ENST00000479757 | SEC13 | chr3 | 10362734 | - | GOLPH3L | chr1 | 150634404 | - |
Top |
FusionProtFeatures for SEC13_GOLPH3L |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| SEC13 | GOLPH3L |
| Functions as a component of the nuclear pore complex(NPC) and the COPII coat. At the endoplasmic reticulum, SEC13 isinvolved in the biogenesis of COPII-coated vesicles.{ECO:0000269|PubMed:8972206}. As a component of the GATOR subcomplex GATOR2, functionswithin the amino acid-sensing branch of the TORC1 signalingpathway. Indirectly activates mTORC1 and the TORC1 signalingpathway through the inhibition of the GATOR1 subcomplex(PubMed:23723238). It is negatively regulated by the upstreamamino acid sensors SESN2 and CASTOR1 (PubMed:25457612,PubMed:27487210). {ECO:0000269|PubMed:23723238,ECO:0000269|PubMed:25457612, ECO:0000269|PubMed:27487210}. | Phosphatidylinositol-4-phosphate-binding protein thatmay antagonize the action of GOLPH3 which is required for theprocess of vesicle budding at the Golgi and anterograde transportto the plasma membrane. {ECO:0000269|PubMed:23345592}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for SEC13_GOLPH3L |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| >In-frame_SEC13_ENST00000350697_chr3_10362734_-_GOLPH3L_ENST00000271732_chr1_150634404_-_182aa MVLLKSDSPTGDVLLDETLKHIKATEPTETVQTWIELLTGETWNPFKLQYQLRNVRERIAKNLVEKGILTTEKQNFLLFDMTTHPVTNTT EKQRLVKKLQDSVLERWVNDPQRMDKRTLALLVLAHSSDVLENVFSSLTDDKYDVAMNRAKDLVELDPEVEGTKPSATEMIWAVLAAFNK >In-frame_SEC13_ENST00000350697_chr3_10362734_-_GOLPH3L_ENST00000540514_chr1_150634404_-_182aa MVLLKSDSPTGDVLLDETLKHIKATEPTETVQTWIELLTGETWNPFKLQYQLRNVRERIAKNLVEKGILTTEKQNFLLFDMTTHPVTNTT EKQRLVKKLQDSVLERWVNDPQRMDKRTLALLVLAHSSDVLENVFSSLTDDKYDVAMNRAKDLVELDPEVEGTKPSATEMIWAVLAAFNK |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| >In-frame_SEC13_ENST00000350697_chr3_10362734_-_GOLPH3L_ENST00000271732_chr1_150634404_-_546nt ATGGTACTGCTAAAGTCAGACAGCCCAACAGGTGATGTTTTACTGGATGAAACTCTGAAACACATCAAAGCAACTGAACCCACAGAAACT GTCCAAACATGGATAGAGCTACTCACTGGTGAGACCTGGAACCCCTTCAAATTACAGTACCAGCTGAGAAATGTACGAGAGCGCATCGCA AAGAACCTAGTAGAGAAAGGTATTCTAACCACTGAGAAGCAGAATTTCCTGCTATTTGACATGACTACTCATCCAGTGACCAATACAACA GAGAAACAGCGACTAGTGAAAAAACTTCAAGATAGTGTACTAGAGCGGTGGGTAAATGACCCTCAGCGTATGGACAAGCGAACACTAGCA CTCCTGGTGCTAGCCCACTCCTCTGATGTGCTAGAGAATGTCTTCTCCTCTCTGACAGATGACAAGTATGATGTGGCAATGAATCGAGCC AAGGACTTAGTAGAACTGGACCCTGAAGTGGAAGGGACAAAGCCTAGTGCCACAGAAATGATCTGGGCTGTGCTGGCAGCCTTCAATAAA >In-frame_SEC13_ENST00000350697_chr3_10362734_-_GOLPH3L_ENST00000540514_chr1_150634404_-_546nt ATGGTACTGCTAAAGTCAGACAGCCCAACAGGTGATGTTTTACTGGATGAAACTCTGAAACACATCAAAGCAACTGAACCCACAGAAACT GTCCAAACATGGATAGAGCTACTCACTGGTGAGACCTGGAACCCCTTCAAATTACAGTACCAGCTGAGAAATGTACGAGAGCGCATCGCA AAGAACCTAGTAGAGAAAGGTATTCTAACCACTGAGAAGCAGAATTTCCTGCTATTTGACATGACTACTCATCCAGTGACCAATACAACA GAGAAACAGCGACTAGTGAAAAAACTTCAAGATAGTGTACTAGAGCGGTGGGTAAATGACCCTCAGCGTATGGACAAGCGAACACTAGCA CTCCTGGTGCTAGCCCACTCCTCTGATGTGCTAGAGAATGTCTTCTCCTCTCTGACAGATGACAAGTATGATGTGGCAATGAATCGAGCC AAGGACTTAGTAGAACTGGACCCTGAAGTGGAAGGGACAAAGCCTAGTGCCACAGAAATGATCTGGGCTGTGCTGGCAGCCTTCAATAAA |
| * Fusion transcript sequences (Full-length transcript). |
| >In-frame_SEC13_ENST00000350697_chr3_10362734_-_GOLPH3L_ENST00000271732_chr1_150634404_-_2768nt CCGAGCGCGTTGCTGCCCGGAGGCTCCTACGCCACGGCCCGTCGGGCCCGGCGCCGGAAGTGAGCTGTTCCGAGGCGCCGCCGGGAGCTG CCACGTCCGAGACCTGGAGCAGCCACCGCCGCAATCATGGTACTGCTAAAGTCAGACAGCCCAACAGGTGATGTTTTACTGGATGAAACT CTGAAACACATCAAAGCAACTGAACCCACAGAAACTGTCCAAACATGGATAGAGCTACTCACTGGTGAGACCTGGAACCCCTTCAAATTA CAGTACCAGCTGAGAAATGTACGAGAGCGCATCGCAAAGAACCTAGTAGAGAAAGGTATTCTAACCACTGAGAAGCAGAATTTCCTGCTA TTTGACATGACTACTCATCCAGTGACCAATACAACAGAGAAACAGCGACTAGTGAAAAAACTTCAAGATAGTGTACTAGAGCGGTGGGTA AATGACCCTCAGCGTATGGACAAGCGAACACTAGCACTCCTGGTGCTAGCCCACTCCTCTGATGTGCTAGAGAATGTCTTCTCCTCTCTG ACAGATGACAAGTATGATGTGGCAATGAATCGAGCCAAGGACTTAGTAGAACTGGACCCTGAAGTGGAAGGGACAAAGCCTAGTGCCACA GAAATGATCTGGGCTGTGCTGGCAGCCTTCAATAAATCTTAAAGCCGGCAGGTGGATTTCTCCTTTTCCCCTGCTGGCTGGTGACTGTCA GAGACCCCATCACTGAGTTTTGTGTGATGAGATGTTTTCATCATTTTTGTTTCCTTTTCTTGAATCAGACTTGTGATTTGGGGAGAGCAA CTTCAGGGCTTCTCCATAGACCTTGACCATTATAAGCAGACCTTATTTCTCCCTACACTTCCACTCCATAGGTAAATAAACTGGGTGAAG CCACACACACCCAATGAACATTTTCTCCCATTTGGTGGTTTAGTTTCACCCAGTGTGCTTTTGGATAAGCAGAAATATCTAAATGGGATT TTGAGTTCTCCAGCTATAGAATGTGAATGAGATAAAAAGTGAACTATCTATTATATTTTTCTGAGTTTGTTTTCTATCATAAATACATGT TTTCACAGCCTTTGTCTCTCAGACTCTGCTAAATAATGTAGCTTATTGAAATAACTGTCGCTGAATAAGGAGCAATGAGAAACAAAACTA ATTTTTGGAGCAGATGGTCTCTGGAATTGCATATCCTGCTAGTGATTTTCTCATCTTTCCTTTTCTAACCTAATGAGAATGTCCCAGATT CAATTACCTGGATGTCAAAGTCCTAGAGCCAGAAATATATTCTCTCATCCCTCTTAGCATTCTCTTGCTCCCTCATTCACTAGGGCAAAT GTCTAAATGAAGAAAAGTCTCTCTCAACACCTCGTTCATGCAATCAGCATTAGAATTTGTAAGGAAGGAAGGGGGGTGGCATGAAAATTT CCATTCTTGGGGTATATGACTGTCCTGTTTCCCCCAGGCCACTTTTTTTTTTTTTTTCTTTTGAGACAGGGTCTTGCTCTTGCCCAGGCA GGAGTACAGTAGTGCAATCACAGCTGACTGCAGCCTTGACCTCCAGGGCTCAAGGATCCTCCTGCCTCAGTCTCCCAACTAAGTGGGACT ACAGGCACGTGCCACCATACTCAGCTTTTTTTTGTTTGTTTTAGACAAGAGTCTCGCTTTGTTGCCCAGGCTGGTCTTGAATTCCTGGGC TCAAGCAATTCTTCCACCTCAGCCTCCCAAAGTGCTGAGATTACTGGCTTGAGCCACTGCACCCACCCCTCCAGACTACTTTAAATGTCT CTGCTCTGACTGAATTGAAGGAATTGTAAGTTTCAGTTGCTGAATATATCAGTATATCTGAACTCCAGATCTTTTTATTTCCTATTTTTG GCTTCCTACATAAATTAATAAAGTCTGTCTATATTTAAGGTTTCTGGGAGTAGTTTTGTCTATATTTAATCCATAGATGTGCTCCTAGTC ATCAGTCTTATTTCAGTAAAACCATCTTTCTGGCCAAATCTCTAACACGTTTTTTACTTCAGTAGTGAGGGCAATGAGAAGCTTTATTAA GAAAGATCCTATTTAAAGGGCTAATTTGGTATTGAAAGCATGCTGATATAAAGTCCAGTATTTGAGGATATAAAGAGGATGTGCACTGAG CTGTGCTGATGTTCAGCATTTATTATACTTTAATGGGATAGTGCTTCTTGACCATTATAGAACAACAAACTGTCAAAGGGTTAATACAGA TGACCCAGACCTGACATTAAATCCTCTTGATTAGAAATAATTAAATGAATTATTTATTCATTTCTCTCCTCTGCCAAATCTACTTAGCCC CACAAAAATGCCCCAGCTCAGTTAACATTTTTTTGTTTTTCACTTTAGGTATCTCTTAGGCAAATAGAGATATAAATTGTAATAGGAAAC AGTCTCTAAATGTGAGGCTGAATACAGCTTCAGTCTGGCTCTCTAATAGGACAAAAGCCAGTCCATGTGTTGTCTCTAACTGATTTAGCT TTTTCTTTTCTTTGAACAATTCGGCATGAATTGAAACCAGGTTTTCCTGTGGAAAGTTATAGCTTGATTGGGAGATAGAAGTTGAATTGA GTTCTTTCTTGCAACTCTTAGTGTTTATTTTTATATCTCAGTAAGACGAGGATACCTTCAGTTTGAATCTGCATAATGTTCACTGCCAAA >In-frame_SEC13_ENST00000350697_chr3_10362734_-_GOLPH3L_ENST00000540514_chr1_150634404_-_782nt CCGAGCGCGTTGCTGCCCGGAGGCTCCTACGCCACGGCCCGTCGGGCCCGGCGCCGGAAGTGAGCTGTTCCGAGGCGCCGCCGGGAGCTG CCACGTCCGAGACCTGGAGCAGCCACCGCCGCAATCATGGTACTGCTAAAGTCAGACAGCCCAACAGGTGATGTTTTACTGGATGAAACT CTGAAACACATCAAAGCAACTGAACCCACAGAAACTGTCCAAACATGGATAGAGCTACTCACTGGTGAGACCTGGAACCCCTTCAAATTA CAGTACCAGCTGAGAAATGTACGAGAGCGCATCGCAAAGAACCTAGTAGAGAAAGGTATTCTAACCACTGAGAAGCAGAATTTCCTGCTA TTTGACATGACTACTCATCCAGTGACCAATACAACAGAGAAACAGCGACTAGTGAAAAAACTTCAAGATAGTGTACTAGAGCGGTGGGTA AATGACCCTCAGCGTATGGACAAGCGAACACTAGCACTCCTGGTGCTAGCCCACTCCTCTGATGTGCTAGAGAATGTCTTCTCCTCTCTG ACAGATGACAAGTATGATGTGGCAATGAATCGAGCCAAGGACTTAGTAGAACTGGACCCTGAAGTGGAAGGGACAAAGCCTAGTGCCACA GAAATGATCTGGGCTGTGCTGGCAGCCTTCAATAAATCTTAAAGCCGGCAGGTGGATTTCTCCTTTTCCCCTGCTGGCTGGTGACTGTCA |
Top |
FusionGenePPI for SEC13_GOLPH3L |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| SEC13 | SEC16B, NUP37, NUP160, NUP133, NUP107, NUP85, SEC31A, RAB11A, SEC13, SIRT7, STAM2, CUL3, SEC23A, SLC12A2, RAD52, BAG3, CLDN12, MAPK9, EGFR, POLR2E, PRPF19, PSMB1, CSNK1A1, CSNK1E, FUS, TRAF5, RNF2, BCR, SPDL1, NUP98, SEH1L, MIOS, PRPF38A, WDR59, WDR24, STX7, ACY1, NUP43, MED4, TFG, QRICH1, SESN2, HSPB1, AHSA1, FLNB, NAPRT, SARS, SEC23B, SEPHS1, SEC24B, IFI16, EWSR1, B9D2, XPO1, CLTB, CLTC, FLNA, GAK, PICALM, AP1S2, SEC16A, GTSE1, MCM2, PPWD1, ZBTB5, CCDC94, FLYWCH2, WDR92, EDEM3, BRCA1 | GOLPH3L | ELAVL1, VCP, HTT, LNX1, SHMT2, MOV10, ZDHHC17, RWDD2B, PNKD, C3orf58, ARL6IP1, GPRC5C, P2RX1, CHST6, C5AR2, S1PR1, TNFRSF8, GLB1L2, SLC39A5, ENTPD7 |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for SEC13_GOLPH3L |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for SEC13_GOLPH3L |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|